Psychiatric illnesses in inflammatory bowel diseases - Psychiatric comorbidity and biological underpinnings;Zaburzenia psychiczne w nieswoistych zapaleniach jelit - Wspólistniejace zaburzenia psychiczne i mechanizmy biologiczne

Psychiatria Polska

Volumn 50, Issue 6, 2016, Pages 1157-1166

  Nowakowski, Jarosław ^a   Chrobak, Adrian A ^a   Dudek, Dominika ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Depressive disorders; Inflammatory bowel disease; Vagus nerve

Indexed keywords

ANXIETY; ARTICLE; BIPOLAR DISORDER; COMORBIDITY; CROHN DISEASE; DEPRESSION; DISEASE SEVERITY; HUMAN; IMMUNOPATHOLOGY; INFLAMMATORY BOWEL DISEASE; MENTAL DISEASE; OXIDATIVE STRESS; RELAPSE; ULCERATIVE COLITIS; VAGUS NERVE DISEASE; COGNITIVE DEFECT; FEMALE; HEALTH STATUS; INFLAMMATORY BOWEL DISEASES; MALE; PSYCHOLOGY; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX;

ANXIETY; COGNITION DISORDERS; COMORBIDITY; DEPRESSION; FEMALE; HEALTH STATUS; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX;

EID: 85011063378     PISSN: 00332674     EISSN: 23915854     Source Type: Journal    
DOI: 10.12740/PP/62382     Document Type: Article

References (46)

1. Graff LA, Walker JR, Bernstein CN. Depression and anxiety in inflammatory bowel disease: A review of comorbidity and management. Inflamm. Bowel Dis. 2009;15(7):1105-1118.
2. Mikocka-Walus A, Turnbull D, Moulding NT, Wilson IG, Andrews JM, Holtmann GJ. Controversies surrounding the comorbidity of depression and anxiety in inflammatory bowel disease patients: A literature review. Inflamm. Bowel Dis. 2007;13(2):225-234.
3. Bennebroek Evertsz F, Thijssens N A M, Stokkers P C F, Grootenhuis A, Bockting C L H, Nieuwkerk PT. i wsp. Do Inflammatory Bowel Disease patients with anxiety and depressive symptoms receive the care they need? J. Crohns Colitis 2012;6(1):68-76.
4. Jang BI, Kim KO, Jeon SW. Predictive factors of impaired quality of life in Korean patients with inactive inflammatory bowel disease: association with functional gastrointestinal disorders and mood disorders. J. Clin. Gastroenterol. 2013;47(4):38-44.
5. Cohen BL, Zoëga H, Shah SA, Leleiko N, Lidofsky S, Bright R. i wsp. Fatigue is highly associated with poor health-related quality of life, disability and depression in newly-diagnosed patients with inflammatory bowel disease, independent of disease activity. Aliment. Pharmacol. Ther. 2014;39(8):811-822.
6. Walker JR, Ediger JP, Graff LA, Greenfeld JM, Clara I, Lix L. i wsp. The Manitoba IBD cohort study: A population-based study of the prevalence of lifetime and 12-month anxiety and mood disorders. Am. J. Gastroenterol. 2008;103(8):1989-1997.
7. Panara AJ, Yarur AJ, Rieders B, Proksell S, Deshpande AR, Abreu MT. i wsp. The incidence and risk factors for developing depression after being diagnosed with inflammatory bowel disease: a cohort study. Aliment. Pharmacol. Ther. 2014;39(8):802-810.
8. Ananthakrishnan AN, Gainer VS, Cai T, Perez RG, Cheng SC, Savova G. i wsp. Similar risk of depression and anxiety following surgery or hospitalization for Crohn's disease and ulcerative colitis. Am. J. Gastroenterol. 2013;108(4):594-601.
9. Bannaga A, Selinger C. Inflammatory bowel disease and anxiety: links, risks, and challenges faced. Clin. Exp. Gastroenterol. 2015;8:111-117.
10. Ananthakrishnan AN, Gainer VS, Perez RG, Cai T, Cheng SC, Savova G. i wsp. Psychiatric comorbidity is associated with increased risk of surgery in Crohn's disease. Aliment. Pharmacol. Ther. 2013;37(4):445-454.
11. Maconi G, Gridavilla D, Viganò C, Sciurti R, Asthana AK, Furfaro F. i wsp. Perianal disease is associated with psychiatric co-morbidity in Crohn's disease in remission. Int. J. Colorectal Dis. 2014;29:1285-1290.
12. Long MD, Kappelman MD, Martin CF, Chen W, Anton K, Sandler RS. Risk factors for depression in the elderly inflammatory bowel disease population. J. Crohns Colitis 2014;8(2):113-119.
13. Clark JG, Srinath AI, Youk AO, Kirshner MA, McCarthy FN, Keljo DJ. i wsp. Predictors of depression in youth with Crohn disease. J. Pediatr. Gastroenterol. Nutr. 2014;58(5):569-573.
14. Persoons P, Vermeire S, Demyttenaere K, Fischler B, Vandenberghe J, Van Oudenhove L. i wsp. The impact of major depressive disorder on the short - and long-term outcome of Crohn's disease treatment with infliximab. Aliment. Pharmacol. Ther. 2005;22(2):101-110.
15. Kurina LM, Goldacre MJ, Yeates D, Gill LE. Depression and anxiety in people with inflammatory bowel disease. J. Epidemiol. Community Health 2001;55(10):716-720.
16. Eaton WW, Pedersen MG, Nielsen PR, Mortensen PB. Autoimmune diseases, bipolar disorder, and non-affective psychosis. Bipolar Disord. 2010;12(6):638-646.
17. Holroyd S, DePaulo J. Bipolar disorder and Crohn's disease. J. Clin. Psychiatry 1990;51(10):407-409.
18. Carson HJ, Dudley MH, Knight LD, Lingamfelter D. Psychosocial complications of Crohn's disease and cause of death. J. Forensic Sci. 2014;59(2):568-570.
19. Mahadev S, Young JM, Selby W, Solomon MJ. Self-reported depressive symptoms and suicidal feelings in perianal Crohn's disease. Colorectal Dis. 2012;14(3):331-335.
20. Berk M, Williams LJ, Jacka FN, O'Neil A, Pasco JA, Moylan S. i wsp. So depression is an inflammatory disease, but where does the inflammation come from? BMC Med. 2013;11:200.
21. Martin-Subero M, Anderson G, Kanchanatawan B, Berk M, Maes M. Comorbidity between depression and inflammatory bowel disease explained by immune-inflammatory, oxidative, and nitrosative stress; tryptophan catabolite; and gut-brain pathways. CNS Spectr. 2016;21(2):184-198.
22. Dantzer R, Connor J C O, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 2008;9(1):46-56.
23. Raison CL, Demetrashvili M, Capuron L, Miller AH. Neuropsychiatric adverse effects of interferon-alpha. CNS Drugs 2005;19(2):105-123.
24. Guloksuz S, Wichers M, Kenis G, Russel MG, Wauters A, Verkerk R. i wsp. Depressive symptoms in Crohn's disease: relationship with immune activation and tryptophan availability. PLoS One 2013;8(3):e60435.
25. Horst S, Chao A, Rosen M, Nohl A, Duley C, Wagnon JH. i wsp. Treatment with immunosuppressive therapy may improve depressive symptoms in patients with inflammatory bowel disease. Dig. Dis. Sci. 2014;60(2):465-470.
26. Catana CS, Berindan Neagoe I, Cozma V, Magdas C, Tabaran F, Dumitrascu DL. Contribution of the IL-17/IL-23 axis to the pathogenesis of inflammatory bowel disease. World J. Gastroenterol. 2015;21(19):5823-5830.
27. Wilkowska A, Pikula M, Rynkiewicz A, Szulc-Wdowczyk J, Trzonkowski P, Landowski J. Wzrost stezenia cytokin prozapalnych w osoczu pacjentów po zawale miesnia sercowego a obecnosc depresji w okresie nastepnych 6 miesiecy. Psychiatr. Pol. 2015;49(3):455-464.
28. Siwek M, Szewczyk B, Dudek D, Styczen K, Sowa-Kucma M, Mlyniec K. i wsp. Zinc as a marker of affective disorders. Pharmacol. Rep. 2013;65(6):1512-1518.
29. Vashum KP, McEvoy M, Milton AH, McElduff P, Hure A, Byles J. i wsp. Dietary zinc is associated with a lower incidence of depression: Findings from two Australian cohorts. J. Affect. Disord. 2014;166:249-257.
30. Caradonna L, Amati L, Magrone T, Pellegrino NM, Jirillo E, Caccavo D. Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance. J. Endotoxin Res. 2000;6(3):205-214.
31. Funderburg NT, Stubblefield Park SR, Sung HC, Hardy G, Clagett B, Ignatz-Hoover J. i wsp. Circulating CD4+ and CD8+ T cells are activated in inflammatory bowel disease and are associated with plasma markers of inflammation. Immunology 2013;140(1):87-97.
32. Maes M, Kubera M, Leunis JC, Berk M. Increased IgA and IgM responses against gut commensals in chronic depression: Further evidence for increased bacterial translocation or leaky gut. J. Affect. Disord. 2012;141:55-62.
33. Maes M. The cytokine hypothesis of depression: Inflammation, oxidative & nitrosative stress (IO&NS) and leaky gut as new targets for adjunctive treatments in depression. Neuro Endocrinol. Lett. 2008;29(3):287-291.
34. Severance EG, Gressitt KL, Yang S, Stallings CR, Origoni AE, Vaughan C. i wsp. Seroreactive marker for inflammatory bowel disease and associations with antibodies to dietary proteins in bipolar disorder. Bipolar Disord. 2014;16(3):230-240.
35. Juchnowicz-Karakula H, Dzikowski M, Pelczarska A, Dzikowska I, Juchnowicz D. Znaczenie zaburzenia osi jelitowo-mózgowej i nadwrazliwosci na antygeny pokarmowe w etiopatogenezie schizofrenii. Psychiatr. Pol. 2015 [Epub ahead of print]; DOI: http://dx.doi.org/10.12740/PP/OnlineFirst/45053.
36. West J, Logan RF, Hubbard RB, Card TR. Risk of schizophrenia in people with coeliac disease, ulcerative colitis and Crohn's disease: A general population-based study. Aliment. Pharmacol. Ther. 2006;23(1):71-74.
37. Rezaie A, Parker RD, Abdollahi M. Oxidative stress and pathogenesis of inflammatory bowel disease: An epiphenomenon or the cause? Dig. Dis. Sci. 2007;52(9):2015-2021.
38. Debnath M, Doyle KM, Langan C, McDonald C, Leonard B, Cannon DM. Recent advances in psychoneuroimmunology: Inflammation in psychiatric disorders. Transl. Neurosci. 2011;2(2):121-137.
39. Hisamatsu T, Okamoto S, Hashimoto M, Muramatsu T, Andou A, Uo M. i wsp. Novel, objective, multivariate biomarkers composed of plasma amino acid profiles for the diagnosis and assessment of inflammatory bowel disease. PLoS One 2012;7(1):e31131.
40. Matteoli G, Boeckxstaens GE. The vagal innervation of the gut and immune homeostasis. Gut 2013;62(8):1214-22.
41. Ghia J, Blennerhassett P, Collins SM. Impaired parasympathetic function increases susceptibility to inflammatory bowel disease in a mouse model of depression. J. Clin. Invest. 2008;118(6):2209-2218.
42. Ghia JE, Blennerhassett P, Deng Y, Verdu EF, Khan WI, Collins SM. Reactivation of inflammatory bowel disease in a mouse model of depression. Gastroenterology 2009;136(7):2280-2288.
43. Ciesielczyk K, Thor PJ. Zaburzenia kontroli nerwowej przewodu pokarmowego i ból trzewny w nieswoistych chorobach zapalnych jelit. Post. Hig. Med. Dosw. 2013;67:304-314.
44. Iskandar HN, Cassell B, Kanuri N, Gyawali CP, Gutierrez A, Dassopoulos T. i wsp. Tricyclic antidepressants for management of residual symptoms in inflammatory bowel disease. J. Clin. Gastroenterol. 2014;48(5):423-429.
45. Surowka AD, Krygowska-Wajs A, Ziomber A, Thor P, Chrobak AA, Szczerbowska-Boruchowska M. Peripheral vagus nerve stimulation significantly affects lipid composition and protein secondary structure within dopamine-related brain regions in rats. Neuromolecular. Med. 2015;17(2):178-191.
46. Barreiro-de Acosta M, Gisbert JP. Letter: psychological remission - a future endpoint in inflammatory bowel disease? Aliment. Pharmacol. Ther. 2014;39(12):1436-1436.